Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.

Ke ZhuLiu XiaoqiangWen DengGongxian WangBin Fu

Published in: Lipids in health and disease (2021)

In conclusion, the current study identified a reliable signature based on 11-LRGs for predicting the prognosis and response to immunotherapy in patients with BLCA. Five small molecule drugs were identified for the treatments of BLCA patients.

Keyphrases

small molecule
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
genome wide
drug induced
copy number
transcription factor
protein protein